Clincosm LogoSign in Get a demo

SARS-CoV-2 Infection

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2 (Omi XBB.1.5)
  • Dublin, California
  • +14 more
Aug 10, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in Miami (Famotidine, Celecoxib,

Active, not recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • Miami, Florida
    US02-04: Integrated Health Solutions
Aug 15, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

SARS-CoV-2 Infection Trial in Miami, Springfield (COVID-HIG)

Completed
  • SARS-CoV-2 Infection
  • COVID-HIG
  • Miami, Florida
  • +1 more
Jun 15, 2022

SARS-CoV-2 Infection Trial in Worldwide (Intramuscular injection, Intramuscular vaccine)

Active, not recruiting
  • SARS-CoV-2 Infection
  • Intramuscular injection
  • Intramuscular vaccine
  • Birmingham, Alabama
  • +90 more
Apr 4, 2022

Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),

Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
Mar 23, 2022

Covid19, Coronavirus, SARS-CoV-2 Infection Trial in United States (Rayaldee 30Mcg Extended-Release (ER) Capsule, Placebo)

Completed
  • Covid19
  • +2 more
  • Rayaldee 30Mcg Extended-Release (ER) Capsule
  • Placebo
  • San Francisco, California
  • +9 more
Oct 14, 2021